Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Sio Gene Therapies Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 55 | +3 |
| Shares | 20.6M | 81.3K | 18.4M | −2.17M (−10.6%) |
| Value | $56.1M | $222.0K | $39.9M | −$16.0M (−28.7%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Sio Gene Therapies Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 812,603 | $1.76M | 0.00% |
| Bank of Montreal | 438,907 | $935.0K | 0.00% |
| Franklin Resources Inc | 82,500 | $179.0K | 0.00% |
| Marshall Wace, LLP | 47,537 | $103.0K | 0.00% |
| Two Sigma Securities, LLC | 13,061 | $28.0K | 0.01% |
| Qube Research & Technologies Ltd | 11,920 | $26.0K | 0.00% |
| SG3 Management, LLC | 9,230 | $20.0K | 0.01% |
| TCI Wealth Advisors, Inc. | 1,400 | $3.00K | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 5 | $0 | 0.00% |
Sold out (6)
Institutions that held Sio Gene Therapies Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Consonance Capital Management LP | 2,969,987 | $8.11M |
| Cubist Systematic Strategies, LLC | 27,452 | $75.0K |
| Federation des caisses Desjardins du Quebec | 2,300 | $6.28K |
| FFT Wealth Management LLC | 1,000 | $3.00K |
| AdvisorNet Financial, Inc | 12 | $0 |
| Carolinas Wealth Consulting LLC | 37 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Sio Gene Therapies Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 81,300 | $222.0K |